MUVON Therapeutics hits key milestone in stress incontinence treatment
MUVON Therapeutics - 09-Jan-2025Phase 2 results drive development ahead of 2025 J.P. Morgan Healthcare Conference
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Phase 2 results drive development ahead of 2025 J.P. Morgan Healthcare Conference
Early clinical trials show safety and feasibility of Muvon's innovative cell-based treatment
Muvon therapeutics unveils phase I results, paving the way for innovative muscle repair
No resources found!
No blog posts found!